期刊文献+

肥胖与阿尔茨海默病 被引量:3

Adiposity and Alzheimer's disease
下载PDF
导出
摘要 阿尔茨海默病(AD)是老年人常见的神经系统变性疾病,是痴呆最常见的病因。病理特征为老年斑、神经元纤维缠结、海马锥体细胞变性和神经元缺失。临床起病隐袭、进行性智能衰退伴人格改变。至今引起该疾病的病因不详,但多种危险因素与AD的发生相关。减少β-淀粉样蛋白(Aβ)在脑中的聚积,是治疗和预防AD的措施之一。多项研究证明肥胖与AD的发生密切相关,控制肥胖、缓解认知功能的损害,为AD的预防和治疗提供了新的方向。 Alzheimer's disease (AD) is a neurodegenerative disease in the elderly and is the most common cause of dementia. Pathological features of senile plaques, neurofibrillary tangles,hippocampal pyramidal cell degeneration and neuronal loss. Clinical insidious onset, progressive mental deterioration with personality change. So far, the cause of the disease is unknown. The occurrence of AD is related to many risk factors. One of measures of prevention and treatment this disease is reducing amyloid beta (Aβ) accumulation in the brain. Many studies testify that the occurrence of AD is closely related to adiposity. Control of obesity to alleviate the impairment of cognitive function. Through this measure can provide a new direction for the prevention and treatment of AD.
作者 那琦 吴哲
出处 《中国现代医生》 2013年第12期28-29,33,共3页 China Modern Doctor
关键词 阿尔茨海默病 肥胖 体重指数 Alzheimer disease Adiposity Body mass index
  • 相关文献

参考文献22

  • 1Ritchie K,Lovestone S. The dementias[J]. Lancet,2002,360(9347) : 1759-1766.
  • 2Selkoe DJ. Alzheimer's disease :genotypes,phenotypes and treatments[J]. Science, 1997,275 (5300) : 630-631.
  • 3Cummings JL. Alzheimer's disease[J]. N Engl J Med,2004,351 ( 1 ) :56- 67.
  • 4Luchsinger JA,Tang MX,Shea S,et al. Hypefinsulinemia and risk of Alzheimer disease[J]. Neurology, 2004,63 ( 7 ) : 1187-1192.
  • 5Sano M. Noncholinergic treatment options for Alzheimer's disease[J]. Journal of Clinical Psychiatry,2003,64(Suppl 9) :23-28.
  • 6Poirier P,Giles TD, Bray GA,et al. Obesity and cardiovascular dis- ease : pathophysiology, evaluation and effect of weight loss : An update of the 1997 american heart association scientific statement on obesity and heart disease from the obesity committee of the council on nutri- tion,physical activity, and metabolism[J]. Circulation, 2006,113 (6) : 898 - 918.
  • 7Wahrenberg H,Hertel K,Leijonhufvud BM,et al. Use of waist cir- cumference to predict insulin resistance :retrospective study[J]. BMJ, 2005,330 (7504) : 1363-1364.
  • 8Janssen I, Katzmarzyk PT,Ross R. Waist circumference and not body mass index explains obesity-related health risk[J]. Am J Clin Nutr,2004, 79(3) :379-384.
  • 9Strachan MWJ. Insulin and cognitive function[J]. Lancet,2003,362(93 92) : 1253.
  • 10Farris W,Mansourian S,Chang Y,et al. Insulin-degrading enzyme regulates the levels of insulin,amyloid beta-protein,and the beta- amyloid precursor protein intracellular domain in vivo[J]. Proc Natl A- cad Sci USA ,2003,100(7) :4162-4167.

同被引文献43

  • 1洪霞,衣志勇,张清华,蒋知新,李祯华,张艳琴,方明俊,喻陆,张振馨.吸烟与阿尔茨海默病[J].中国神经免疫学和神经病学杂志,2004,11(3):160-163. 被引量:9
  • 2张望,张健.炎症标志物抵抗素研究进展[J].动物医学进展,2007,28(5):88-90. 被引量:7
  • 3邓娟,周华东,李敬诚,王延江,张猛.吸烟对AD大鼠认知功能和tau蛋白异常磷酸化的影响[J].中国行为医学科学,2007,16(7):591-593. 被引量:3
  • 4国家技术监督局.GB10000-88,中国成年人人体尺寸[S].北京:中国标准化与信息分类编码研究所,1989.
  • 5FarrisW, MansourianS, Leissring MA, et al. Partial lossof Function mu- tations in insulin-degrading enzyme that induce [ J ]. JPathol, 2004,164 (4) :1425 - 1430.
  • 6Sano M. Noncholinergic treatment options for Alzheimer's disease[ J]. Journal of Clinical Psychiatry,2003,64 ( Suppl 9 ) :23 - 285.
  • 7Castri P, Iacovelli L, De Blasi A, et al. Reduced insulin-induced phosphate-ylinositol-3-kinase activation in peripheral blood mononu- clear leucocytes frompatients with Alzheimer's disease [ J ]. Eur J Neu- rosci ,2007,26:2469 - 2472.
  • 8李萍.电针对阿尔茨海默病大鼠行为学及海马区IL.1,IL-6的影响[D].湖北中医药大学,2010.
  • 9Morinaga H, Talukdar S, et al. Increased macrophagemigration into ad- ipose tissue in obese mice~ J~. Diabetes,2012,61 (2) :346 -354.
  • 10Glass C K. Macrophages, inflammation, andinsulin resistance [ J ] Annu Rev Physio1,2010 ,72 :219 - 246.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部